Dmd067868 209..219

Abstract

The thiouracil derivative PF-06282999 [2-(6-(5-chloro-2-methoxyphenyl)4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide] is an irreversible inactivator of myeloperoxidase and is currently in clinical trials for the potential treatment of cardiovascular diseases. Concerns over idiosyncratic toxicity arising from bioactivation of the thiouracil motif to… (More)

Topics

12 Figures and Tables

Cite this paper

@inproceedings{Dong2016Dmd0678682, title={Dmd067868 209..219}, author={Jennifer Q. Dong and M. Vishaal Varma and Angela C. Wolford and Tim F. Ryder and Li Di and Bo Feng and Steven G Terra and Kazuko Sagawa and Amit S. Kalgutkar}, year={2016} }